Detalhe da pesquisa
1.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Oncologist
; 28(2): 139-148, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367377
2.
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
Eur Radiol
; 33(12): 9254-9261, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368111
3.
Design of placebo-controlled randomized trials of anticancer agents: Ethical considerations based on a review of published trials.
Clin Trials
; 18(6): 690-698, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693757
4.
Emerging Therapeutic Implications of STK11 Mutation: Case Series.
Oncologist
; 25(9): 733-737, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396674
5.
Mitotane and the myth of 14 mg/L.
Lancet Oncol
; 25(1): 12-15, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181804
6.
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
Cancer
; 125(3): 406-415, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341983
7.
The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype.
Oncologist
; 29(4): 275-277, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498045
8.
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Oncologist
; 24(1): 16-e14, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297385
9.
Waiting for ASCO to "Walk the Walk".
Oncologist
; 28(11): 921-924, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774404
10.
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
Cell Mol Neurobiol
; 38(5): 1099-1106, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623478
11.
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung.
Anticancer Drugs
; 29(5): 457-465, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420340
12.
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.
Lancet Oncol
; 18(1): 143-154, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979599
13.
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.
Oncologist
; 22(8): 888-e84, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679644
14.
Precision oncology: origins, optimism, and potential.
Lancet Oncol
; 17(2): e81-e86, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26868357
15.
Inappropriate censoring in Kaplan-Meier analyses.
Lancet Oncol
; 22(10): 1358-1360, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592177
16.
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.
Oncologist
; 21(3): 261-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888691
17.
Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.
Clin Endocrinol (Oxf)
; 85(1): 62-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26998836
18.
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Endocr Pract
; 22(3): 302-14, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26523625
19.
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.
Br J Haematol
; 170(1): 96-109, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891346
20.
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials.
Oncologist
; 20(4): 400-10, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795635